Form 8-K · Current report
FedEx 8-K, filed Sep 14, 2026
- Filed
- CIK
- 0001048911
- Accession no.
- 0001104659-26-107511
Summary
FedEx Corporation and three wholly owned subsidiaries entered underwriting agreements on September 9, 2026 for a €2 billion euro-denominated notes offering and a $1.1 billion dollar-denominated notes offering, both of which were consummated on September 14, 2026. The notes carry fixed coupons of 4.000% due 2030, 4.625% due 2034, and 5.750% due 2036.
Key points
- FedEx agreed to issue €1,100,000,000 of 4.000% notes due 2030 and €900,000,000 of 4.625% notes due 2034.
- FedEx agreed to issue $1,100,000,000 of 5.750% notes due 2036.
- The euro and dollar notes offerings were both consummated on September 14, 2026, with underwriting agreements dated September 9, 2026.
- The filing incorporates the related exhibits into FedEx's Form S-3 registration statement (No. 333-297595).
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01. Other Events. On September 9, 2026, FedEx Corporation (the “Company”) and the Company’s wholly owned subsidiaries Federal Express Corporation, Federal Express International, Inc. and Federal Express Europe, Inc. entered into (i) an underwriting agreement (the “Euro Notes Underwriting Agreement”) with Citigroup Global Markets Limited, Merrill Lynch International, Wells Fargo Securities International Limited, BNP PARIBAS and ING Bank N.V., on behalf of themselves and as representatives of the several underwriters named on Schedule B to the Euro Notes Underwriting Agreement, in connection with the issuance and sale by the Company of €1,100,000,000 aggregate principal amount of the…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.